XFOR - X4 Pharmaceuticals - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

XFOR is currently covered by 2 analysts with an average price target of $6.25. This is a potential upside of $118.89 (78.57%) from yesterday's end of day stock price of $3.5.

X4 Pharmaceuticals's activity chart (see below) currently has 16 price targets and 27 ratings on display. The stock rating distribution of XFOR is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 62.22% with an average time for these price targets to be met of 389.53 days.

Highest price target for XFOR is $7.5, Lowest price target is $5, average price target is $6.25.

Most recent stock forecast was given by from HC WAINWRIGHT on 10-Nov-2025. First documented stock forecast 11-Dec-2017.

Currently out of the existing stock ratings of XFOR, 2 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 22-Mar-2023

$5

$0.98 (24.38%)

10 months 4 days ago
(10-Nov-2025)

3/4 (75%)

$1.37 (37.74%)

377

Buy Since 07-Jun-2019

$7.5

$3.48 (86.57%)

$9

10 months 9 days ago
(05-Nov-2025)

2/6 (33.33%)

$3.95 (111.27%)

238

Buy Since 22-Dec-2022

$3

$-1.02 (-25.37%)

1 years 5 months 19 days ago
(26-Mar-2025)

2/2 (100%)

$-5.07 (-62.83%)

464

Buy Since 17-Dec-2020

$4.32

1 years 5 months 20 days ago
(25-Mar-2025)

4/4 (100%)

$-15.78 (-78.51%)

674

Hold Since 12-Dec-2023

$900

1 years 9 months 27 days ago
(18-Nov-2024)

0/1 (0%)

$881.34 (4723.15%)

Show more analysts

Please expand the browser size to see the chart

What is XFOR (X4 Pharmaceuticals) average time for price targets to be met?

On average it took 390 days for the stock forecasts to be reached, with an average price target met ratio of 62.22%.

Which analyst most recently updated their price target on XFOR (X4 Pharmaceuticals)?

Which analyst has the most public recommendations on XFOR (X4 Pharmaceuticals)?

has 0 price targets and 0 ratings on XFOR

Which analyst is the currently most bullish on XFOR (X4 Pharmaceuticals)?

Arlinda Lee with the highest potential upside of $295.96

Which analyst is the currently most reserved on XFOR (X4 Pharmaceuticals)?

Kristen Kluska with the lowest potential downside of -$1.02

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?